4//SEC Filing
LeBel Carl 4
Accession 0001127602-22-019045
CIK 0001703647other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:47 PM ET
Size
8.9 KB
Accession
0001127602-22-019045
Insider Transaction Report
Form 4
LeBel Carl
Chief Development Officer
Transactions
- Sale
Common Stock
2022-07-06$1.52/sh−4,421$6,720→ 26,343 total - Exercise/Conversion
Restricted Stock Unit
2022-07-05−15,000→ 0 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2022-07-05+15,000→ 30,764 total
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 4638 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2022.
- [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.49 to $1.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F5]The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001439275
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:47 PM ET
- Size
- 8.9 KB